NFE2L2 rs35652124C>T polymorphism predicts Grade 4 neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and fluorouracil chemotherapy: results from exploratory and validation cohorts. - Nomura H; Suzuki T; Kojima T; Itoh K; Tsuji D (Cancer chemotherapy and pharmacology, 2026)